EquityBulls

Latest News

Keywords Selected: PSU

Research

SBICAPS Monthly Ecocapsule Dec'24 : FY25 - A TALE OF TWO HALVES OR ONE OF FULL DESPAIR? - Executive Summary

Market Commentary

Stock Report

Apollo Micro Systems Ltd declared lowest bidder for orders worth Rs. 25.78 crores
Department of Drug Controller directs Natural Capsules Ltd to close operations of plant
Shelter Pharma Limited Launches D3 Cure Capsules
ZIM Laboratories Ltd receives approval from CDSCO - Directorate General of Health Services for Naproxen + Esomeprazole Capsules
Zydus receives final approval from USFDA for Diroximel Fumarate Delayed-Release Capsules, 231 mg
Alembic Pharmaceuticals Ltd announces USFDA Final Approval Dexlansoprazole Delayed Release Capsules, 30 mg and 60 mg
Zydus receives approval from China's NMPA for Venlafaxine Extended-Release Capsules, 75 mg and 150 mg
Zydus receives tentative approval from USFDA for Budesonide delayedrelease capsules, 4 mg
Aurionpro extends its winning momentum in Transaction Banking with another major Indian Public Sector Bank Deal
SBI strengthens presence in Tamil Nadu with the inauguration of 14 new branches
Lupin receives approval from U.S. FDA for Lenalidomide Capsules
Zydus and Synthon entered into exclusive licensing and supply agreement for Ozanimod Capsules for the U.S. market
DEE Development Engineers Ltd receives LoI from Indian PSU
Apollo Micro Systems Ltd declared lowest bidder for orders worth Rs. 25.12 crores
Deccan Gold Mines Makes First-Ever Nickel-Copper-Platinum Group Sulphide Discovery in India
Zydus receives final approval from USFDA for Celecoxib Capsules, 50 mg, 100 mg, 200 mg and 400 mg
Aayush Wellness Ltd launches Brain Fuel Capsules
Confidence Petroleum India Ltd secures bottling assistance contracts from PSUs
Zydus receives final approval from USFDA for Isotretinoin Capsules USP, 10 mg 20 mg, 25 mg, 30 mg, 35 mg and 40 mg
Strides strengthens Anti-Inflammatory Portfolio with USFDA Approval for Celecoxib Capsules, 100 mg, 200 mg, and 400 mg
Tiger Logistics Fuels Growth with New Projects in Government & PSU Business
ZIM Laboratories Ltd receives Marketing Authorization for Dimethyl Fumarate (120 mg & 240 mg) Modified Release Capsules in Portugal, Europe
Alembic Pharmaceuticals Ltd announces USFDA Final Approval for Divalproex Sodium Delayed-Release Capsules USP, 125 mg
Alembic Pharmaceuticals announces USFDA Final Approval for Diltiazem Hydrochloride Extended-Release Capsules USP, 120 mg, 180 mg, and 240 mg

Mutual Funds